---
schema_version: '1.0'
id: news-20260730-9815af
url: https://www.afpbb.com/articles/-/3646237
url_hash: 9815afeff605d396a3473fbf1888b06f4a5dc229901644f7f5e5fa8a968e2732
canonical_url: https://www.afpbb.com/articles/-/3646237
source: bing
category: news/world
category_raw: world
region: JP
tags:
- world
- AFPBB News
lang: ja
published_at: '2026-07-29T17:00:00Z'
fetched_at: '2026-07-30T05:10:37.379379Z'
updated_at: '2026-07-30T05:10:57Z'
status: published
content_hash: null
content_changed_at: null
license_note: link-only
summary: null
summary_source: null
summary_en: null
entities:
- name: World
  type: location
- name: AFPBB News
  type: UNKNOWN
- name: IceCreamSales
  type: data
key_facts: []
related: []
related_auto:
- name: China
  type: organization
  weight: 1.0
- name: ホルムズ海峡
  type: location
  weight: 1.0
- name: CommonFactor
  type: UNKNOWN
  weight: 1.0
title: 思捷優達-KY、AI創薬による主力候補薬YA-101の多系統萎縮症（MSA）に ...
---

# 思捷優達-KY、AI創薬による主力候補薬YA-101の多系統萎縮症（MSA）に ...

## TL;DR
（要約なし・原文はリンク先を参照 / No summary available; see the source link.）

## Key Points
- world / AFPBB News

## Details
(本文なし。リンク先参照)

## Source
元記事: [思捷優達-KY、AI創薬による主力候補薬YA-101の多系統萎縮症（MSA）に ...](https://www.afpbb.com/articles/-/3646237) — published 2026-07-29T17:00:00Z